IN161611B - - Google Patents
Info
- Publication number
- IN161611B IN161611B IN536/DEL/84A IN536DE1984A IN161611B IN 161611 B IN161611 B IN 161611B IN 536DE1984 A IN536DE1984 A IN 536DE1984A IN 161611 B IN161611 B IN 161611B
- Authority
- IN
- India
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8311250A FR2548664B1 (fr) | 1983-07-06 | 1983-07-06 | Derives 7-(pyrrol-l-yl) des acides l-ethyl-1,4-dihydro-4-oxoquinoleine-3-carboxyliques et l-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridine)-3-carboxyliques substitues, leur preparation et leur application en tant que medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN161611B true IN161611B (enExample) | 1988-01-02 |
Family
ID=9290571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN536/DEL/84A IN161611B (enExample) | 1983-07-06 | 1984-07-03 |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPS6036482A (enExample) |
| FR (1) | FR2548664B1 (enExample) |
| IN (1) | IN161611B (enExample) |
| RO (1) | RO88915B (enExample) |
| SU (1) | SU1322980A3 (enExample) |
| ZA (1) | ZA844693B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1221492B (it) * | 1984-03-13 | 1990-07-06 | Biochem Design Srl | Acidi 7-(1-pirril)-e 7-(1-pirroli-dinil)-6-fluoro-1-etil-1,4-diidro-4-chetochinolin-3-carbossilici ad attivita' antimicrobiche,loro procedimento di preparazione e composti farmaceutici che li contengono |
| US6080756A (en) * | 1995-08-29 | 2000-06-27 | Pfizer Inc. | Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin |
| ES2200439T3 (es) * | 1995-09-22 | 2004-03-01 | Wakunaga Pharmaceutical Co., Ltd. | Intermedios para utilizar en la preparacion de nuevos derivados del acido piridonocarboxilico o sus sales. |
| CN1264837C (zh) * | 1997-09-15 | 2006-07-19 | 普罗克特和甘保尔公司 | 喹诺酮抗微生物剂、其组合物和应用 |
| HK1044476B (zh) | 1999-03-17 | 2010-09-17 | 第一制药株式会社 | 药物组合物 |
| MXPA02000103A (es) * | 1999-07-01 | 2003-07-21 | Wakunaga Pharma Co Ltd | Derivado de acido quinolin carboxilico o sales del mismo. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2362553A1 (de) * | 1972-12-18 | 1974-06-20 | Dainippon Pharmaceutical Co | Neue piperazinderivate |
| JPS5233694A (en) * | 1975-09-09 | 1977-03-14 | Dai Ichi Seiyaku Co Ltd | Process for preparation of 6_nitro-1,8-naphthyridine derivatives |
| AR223983A1 (es) * | 1978-08-25 | 1981-10-15 | Dainippon Pharmaceutical Co | Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico |
-
1983
- 1983-07-06 FR FR8311250A patent/FR2548664B1/fr not_active Expired
-
1984
- 1984-06-21 ZA ZA844693A patent/ZA844693B/xx unknown
- 1984-07-03 RO RO115120A patent/RO88915B/ro unknown
- 1984-07-03 IN IN536/DEL/84A patent/IN161611B/en unknown
- 1984-07-04 JP JP59138851A patent/JPS6036482A/ja active Granted
- 1984-07-05 SU SU843759901A patent/SU1322980A3/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| JPH026756B2 (enExample) | 1990-02-13 |
| FR2548664B1 (fr) | 1986-03-21 |
| JPS6036482A (ja) | 1985-02-25 |
| ZA844693B (en) | 1985-02-27 |
| SU1322980A3 (ru) | 1987-07-07 |
| FR2548664A1 (fr) | 1985-01-11 |
| RO88915B (ro) | 1987-07-01 |
| RO88915A (ro) | 1987-06-30 |